HAE
Haemonetics Corporation
$54.54
+$0.20(+0.37%)
61
Overall
75
Value
63
Tech
47
Quality
Market Cap
$2.66B
Volume
826.52K
52W Range
$50.68 - $94.99
Target Price
$80.82
Order:
Income Statement
| Metric | Trend | Chart | 2016 Mar | 2017 Mar | 2018 Mar | 2019 Mar | 2020 Mar | 2021 Mar | 2022 Mar | 2023 Mar | 2024 Mar | 2025 Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $908.8M | $886.1M | $903.9M | $967.6M | $988.5M | $870.5M | $993.2M | $1.2B | $1.3B | $1.4B | ||
| Total Revenue | $908.8M | $886.1M | $903.9M | $967.6M | $988.5M | $870.5M | $993.2M | $1.2B | $1.3B | $1.4B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $502.9M | $507.6M | $-492.0M | $550.0M | $504.0M | $472.6M | $487.7M | $553.6M | $617.5M | $611.9M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $405.9M | $378.5M | $411.9M | $417.5M | $484.5M | $397.8M | $505.5M | $615.1M | $691.5M | $749.0M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $362.2M | $339.3M | $-355.8M | $334.0M | $381.2M | $308.1M | $424.8M | $459.1M | $526.7M | $547.8M | ||
| Research & Development | $45.0M | $37.6M | $39.2M | $35.7M | $30.9M | $32.9M | $46.8M | $50.1M | $54.4M | $62.7M | ||
| Research Expense | $45.0M | $37.6M | $39.2M | $35.7M | $30.9M | $32.9M | $46.8M | $50.1M | $54.4M | $62.7M | ||
| Selling, General & Administrative | $317.2M | $301.7M | $316.5M | $298.3M | $282.0M | $274.2M | $340.1M | $376.7M | $431.8M | $436.8M | ||
| Selling & Marketing Expenses | $317.2M | $301.7M | $316.5M | $4.5M | $4.3M | $2.7M | $4.4M | $7.2M | $7.1M | -- | ||
| General & Administrative Expenses | -- | $-6.2M | $-6.4M | $298.3M | $282.0M | $274.2M | $340.1M | $376.7M | $431.8M | $436.8M | ||
| Promotion & Advertising | -- | $-2.5M | $-3.1M | $4.5M | $4.3M | $2.7M | $4.4M | -- | -- | -- | ||
| Salaries & Wages | -- | $-9.2M | $-13.0M | $3.1M | $6.6M | $2.1M | $24.4M | -- | -- | -- | ||
| Depreciation & Amortization | -- | $-89.7M | $-89.2M | $109.4M | $25.7M | $84.3M | $97.7M | $93.3M | $97.2M | -- | ||
| Depreciation & Amortization | -- | $-89.7M | $-89.2M | $109.4M | $25.7M | $32.8M | $97.7M | -- | -- | -- | ||
| Amortization | -- | $-64.3M | $-57.9M | $186.0M | $25.7M | $-4.9M | $467.5M | $466.3M | $564.9M | -- | ||
| Other Operating Expenses | -- | $-4.6M | $-2.4M | $-282.0K | $-5.6M | $-32.8M | $-3.2M | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $43.7M | $39.2M | $-847.8M | $83.5M | $103.4M | $89.7M | $80.8M | $156.0M | $164.9M | $221.8M | ||
| EBITDA | $36.5M | $54.4M | $141.2M | -- | $210.9M | $174.0M | $181.9M | $251.3M | $249.1M | $327.7M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | $12.6M | $13.5M | $16.8M | $17.1M | $14.6M | $13.0M | -- | ||
| Net Non-Operating Interest Income/Expense | -- | $300.0K | $300.0K | $-12.6M | $-13.5M | $-9.4M | $17.1M | $14.6M | $-19.5M | -- | ||
| Gain on Sale of Securities | -- | -- | $8.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Other Income/Expense | $97.1M | $66.7M | $-907.4M | $9.9M | $66.8M | $17.9M | $9.6M | $382.0K | $21.4M | $-10.9M | ||
| Other Special Charges | $-9.5M | $-8.1M | $899.4M | $-9.9M | $-16.2M | $-16.8M | $-17.1M | $-14.6M | $-13.0M | $-9.7M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | -- | $-21.8M | $-30.5M | $21.2M | $25.7M | $1.4M | $4.2M | -- | -- | -- | ||
| Special Income Charges | -- | $97.2M | $37.9M | $-21.2M | $-12.6M | $-547.0K | $-2.9M | $4.6M | $-7.4M | -- | ||
| Impairment of Capital Assets | -- | $-75.3M | $-4.4M | -- | -- | -- | -- | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-53.4M | $-35.3M | $52.0M | -- | $100.7M | $89.7M | $80.8M | $156.0M | $151.9M | $212.1M | ||
| Pre-Tax Income | $-53.4M | $-27.5M | $59.6M | $73.6M | $87.2M | $72.9M | $63.6M | $141.4M | $151.9M | $212.1M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $2.2M | $-1.2M | $14.1M | $18.6M | $10.6M | $-6.6M | $20.3M | $26.0M | $34.3M | $44.4M | ||
| NET INCOME | ||||||||||||
| Net Income | $-55.6M | $-26.3M | $45.6M | $55.0M | $76.5M | $79.5M | $43.4M | $115.4M | $117.6M | $167.7M | ||
| Net Income (Continuing Operations) | $-55.6M | $-26.3M | $45.6M | $55.0M | $76.5M | $79.5M | $43.4M | $115.4M | $117.6M | $167.7M | ||
| Net Income (Discontinued Operations) | $-55.6M | $-26.3M | $45.6M | $55.0M | $76.5M | $79.5M | $43.4M | $115.4M | $117.6M | $167.7M | ||
| Net Income (Common Stockholders) | $-55.6M | $-26.3M | $45.6M | $55.0M | $76.5M | $79.5M | $43.4M | $115.4M | $117.6M | $167.7M | ||
| Normalized Income | -- | -- | -- | -- | -- | $60.4M | -- | -- | -- | $189.3M | ||
| TOTALS | ||||||||||||
| Total Expenses | $865.1M | $846.9M | $-847.8M | $884.0M | $885.1M | $780.7M | $912.4M | $1.0B | $1.1B | $1.1B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $50.9M | $51.5M | $52.8M | $51.5M | $50.7M | $50.7M | $51.0M | $50.8M | $50.7M | $50.3M | ||
| Average Shares Outstanding (Diluted) | $50.9M | $51.5M | $53.5M | $52.9M | $51.8M | $51.3M | $51.4M | $51.4M | $51.4M | $50.7M | ||
| Shares Outstanding | $51.0M | $52.5M | $52.2M | $51.2M | $50.4M | $51.0M | $51.3M | $50.5M | $50.8M | $48.0M | ||
| Basic EPS | $-1.09 | $-0.51 | $0.86 | $1.07 | $1.51 | $1.57 | $0.85 | $2.27 | $2.32 | $3.33 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | $1.07 | $1.51 | $1.57 | $0.85 | $2.27 | $2.32 | $3.33 | ||
| Diluted EPS | $-1.09 | $-0.51 | $0.85 | $1.04 | $1.48 | $1.55 | $0.84 | $2.24 | $2.29 | $3.31 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | $1.04 | $1.48 | $1.55 | $0.84 | $2.24 | $2.29 | $3.31 | ||
| OTHER METRICS | ||||||||||||
| Gain On Sale Of Business | -- | $-289.0K | -- | -- | -- | -- | $9.6M | -- | -- | -- | ||
| Gain On Sale Of P P E | -- | -- | -- | -- | $8.1M | $8.1M | $-9.6M | -- | $2.0M | -- | ||
| Gains Loss On Disposal Of Discontinued Operations | -- | -- | -- | -- | $8.1M | $32.8M | $9.6M | $382.0K | $2.0M | -- | ||
| Interest Expense Operating | -- | $-7.8M | $-7.7M | $-13.1M | -- | -- | -- | -- | -- | -- | ||
| Net Income Discontinuous Operations | -- | -- | -- | -- | $8.1M | $32.8M | $9.6M | $382.0K | $2.0M | -- | ||
| Non Recurring Operation Expense | -- | -- | $-3.0M | $2.7M | $-8.1M | $-897.0K | $-1.4M | -- | -- | -- | ||
| Other Gand A | -- | $-6.2M | $-6.4M | $298.3M | $282.0M | $274.2M | $340.1M | $376.7M | $431.8M | $436.8M | ||
| Other Impairment Of Capital Assets | $92.4M | $58.6M | $-1.9M | $21.2M | $50.6M | $1.0M | $577.0K | -- | $10.4M | $2.4M | ||
| Other Write Off | -- | -- | -- | -- | $478.0K | $607.0K | $110.0K | -- | -- | -- | ||
| Rent And Landing Fees | -- | $-6.2M | $-6.4M | $6.4M | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $317.2M | $301.7M | $316.5M | -- | -- | -- | -- | -- | -- | -- | ||
| Write Down | -- | -- | -- | -- | $-5.0M | -- | -- | -- | -- | -- | ||
| Restruct | -- | $-21.8M | $-30.5M | $21.2M | $25.7M | $1.4M | $4.2M | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HAE | $54.54 | +0.4% | 826.52K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |